It's We, the Public, Who Are "Flip Floppers"
The failure of health care reform does not rest solely at the president’s feet. Instead, we, the general public, are also to blame…(Read the rest and view comments at Scientocracy)
The failure of health care reform does not rest solely at the president’s feet. Instead, we, the general public, are also to blame…(Read the rest and view comments at Scientocracy)
Studying economics in college at the dawn of the Reagan presidency, I learned about the wonders of free-markets. The invisible hand of the market, I read, guarantees that thousands upon thousands of people–each with unique desires, abilities and values–mesh together, thereby able to achieve the balance of work and leisure, and of material and spiritual…
The hospital price transparency bill that was signed into effect on August 21 has elicited criticism from the Duke health community. House Bill 834 mandates that hospitals and medical care agencies in North Carolina—including Duke University Medical Center—provide pricing information on 140 of the most common health care procedures to the Department of Health and…
In my previous post, I showed a powerful picture (from the Kaiser Family Foundation) of the growth in high deductible insurance plans. Here is another picture from that same report, showing that the high end of these high ends is getting really high. (Click here to view comments)
A quick quiz before we start today’s lesson. What do we call a tree that grows from acorns? What do we call a funny story? What sound does a frog make? What is another word for a cape? What do we call the white part of an egg? On that last question, were you tempted…
In 2006, health-care expenditures in the U.S. rose 6%, a rate of growth significantly higher than inflation and one that, if sustained, would lead to a doubling in health-care spending in a mere dozen years. Some of that extra spending was a function of more doctors doing more things to more people—an increasing number of…
It is well accepted among health economics wonks that the lion’s share of pharmaceutical company profits come when these companies hold exclusive rights to their products. Once their blockbuster pills go “generic,” competitors enter the marketplace and profits plummet. Consider captopril, a groundbreaking heart failure medication introduced in the early 80s by Bristol-Myers Squibb under…